Kalowski Lee
SEC CIK 1618273 · EDGAR
BoughtSold
Most active insiders at QTTB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Xu Diyong | Dir, 10% | $15.00M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $15.00M | — |
| 3 | Morrison Jodie Pope | CEO, Dir | — | $285.5K |
| 4 | Kalowski Lee | CFO, Pres | — | $115.2K |
| 5 | Violette Shelia M. | CSO | — | $59.0K |
| 6 | Manke Isaac | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 16:10 | 2026-08-25 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | S - Sale | $16.56 | -3,972 | 138.5K | -3% | -$65.8K | |
| 2026-07-20 21:25 | 2026-07-16 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | A - Grant | $0.00 | +53.2K | 142.4K | +60% | $0 | |
| 2026-03-20 | 2026-02-24 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | A - Grant | $0.00 | +53.2K | 89.2K | +148% | $0 | |
| 2026-02-27 | 2026-02-25 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | S - Sale | $4.51 | -3,995 | 35.9K | -10% | -$18.0K | |
| 2025-12-04 | 2025-12-02 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | S - Sale | $3.46 | -9,072 | 39.9K | -19% | -$31.4K | |
| 2025-08-28 | 2025-08-26 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | S - Sale | $1.80 | -4,240 | 49.0K | -8% | -$7,632 | |
| D | 2025-02-27 | 2025-02-24 | QTTB | Q32 Bio Inc. | Kalowski Lee | CFO, Pres | A - Grant | $0.00 | +53.2K | 53.2K | New | $0 |
| 2023-04-05 | 2023-04-03 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | S - Sale | $21.11 | -376 | 30.3K | -1% | -$7,937 | |
| D | 2023-01-05 | 2023-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | S - Sale | $29.06 | -1,815 | 30.7K | -6% | -$52.7K |
| D | 2023-01-05 | 2023-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | A - Grant | $0.00 | +17.5K | 32.5K | +117% | $0 |
| D | 2022-01-05 | 2022-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
| D | 2021-09-03 | 2021-09-02 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | S - Sale+OE | $40.00 | -10.0K | 0 | -100% | -$400.0K |
| D | 2021-09-03 | 2021-09-02 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | M - OptEx | $9.82 | +10.0K | 10.0K | New | +$98.2K |
| DM | 2021-08-27 | 2021-08-26+ | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | S - Sale+OE | $35.14 | -8,500 | 0 | -100% | -$298.7K |
| DM | 2021-08-27 | 2021-08-26+ | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | M - OptEx | $8.73 | +8,500 | 550 | New | +$74.2K |
| D | 2021-08-25 | 2021-08-23 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | S - Sale+OE | $33.02 | -7,500 | 0 | -100% | -$247.7K |
| D | 2021-08-25 | 2021-08-23 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | M - OptEx | $1.60 | +7,500 | 7,500 | New | +$12.0K |
| D | 2021-07-30 | 2021-07-29 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | M - OptEx | $1.63 | +12.5K | 12.5K | New | +$20.4K |
| DM | 2021-07-30 | 2021-07-29 | BCYC | BICYCLE THERAPEUTICS PLC | Kalowski Lee | Pres, CFO | S - Sale+OE | $31.51 | -12.5K | 0 | -100% | -$393.8K |
Purchase Sale Sale after option exercise All abbreviations